The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis

Treatment Comparison ◽

Mixed Treatment ◽

Glucagon Like Peptide ◽

Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.12849 ◽

2017 ◽

Vol 19 (4) ◽

pp. 524-536 ◽

Cited By ~ 136

Author(s):

Zin Z. Htike ◽

Francesco Zaccardi ◽

Dimitris Papamargaritis ◽

David R. Webb ◽

Kamlesh Khunti ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Comparison Analysis ◽

Treatment Comparison ◽

Mixed Treatment ◽

Glucagon Like Peptide ◽

Update in Cardiovascular Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes—A Mixed Treatment Comparison Meta-analysis of Randomized Controlled Trials

Diabetes ◽

10.2337/db18-414-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 414-P

Author(s):

OSAMAH ALFAYEZ ◽

MAJED S. AL YAMI ◽

RAZAN ALSHEIKH

Keyword(s):

Meta Analysis ◽

Controlled Trials ◽

Cardiovascular Safety ◽

Treatment Comparison ◽

Randomized Controlled ◽

Mixed Treatment ◽

Glucagon Like Peptide ◽

Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials

Heart Lung and Circulation ◽

10.1016/j.hlc.2018.03.018 ◽

2018 ◽

Vol 27 (11) ◽

pp. 1301-1309 ◽

Cited By ~ 2

Author(s):

Majed S. Al Yami ◽

Osamah M. Alfayez ◽

Razan Alsheikh

Keyword(s):

Randomised Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Treatment Comparison ◽

Mixed Treatment ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Randomised Controlled

Faculty Opinions recommendation of Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733073791.793548836 ◽

2018 ◽

Author(s):

Helmy Siragy

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

All Cause Mortality ◽

Glucagon Like Peptide ◽

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/review1 ◽

2020 ◽

Author(s):

Ling Li

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review6 ◽

2020 ◽

Author(s):

Raquel Comoglio

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review5 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Diabetes Therapy ◽

10.1007/s13300-020-00882-2 ◽

2020 ◽

Vol 11 (9) ◽

pp. 2121-2143

Author(s):

Liyun He ◽

Na Yang ◽

Lingling Xu ◽

Fan Ping ◽

Wei Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.14108 ◽

2020 ◽

Vol 22 (10) ◽

pp. 1857-1868 ◽

Cited By ~ 4

Author(s):

Chrysanthi Mantsiou ◽

Thomas Karagiannis ◽

Panagiota Kakotrichi ◽

Konstantinos Malandris ◽

Ioannis Avgerinos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽